Autologous platelet gel and fibrin sealant enhance the efficacy of total knee arthroplasty: improved range of motion, decreased length of stay and a reduced incidence of arthrofibrosis.
In this study we describe the potential role of autologous platelet gel and fibrin sealant in unilateral total knee arthroplasty to improve the postoperative range of motion and to reduce the incidence of arthrofibrosis. Total knee arthroplasty is often associated with a considerable amount of post-operative blood loss. Persistent limited motion directly after surgery may ultimately result in arthrofibrosis. To counteract these effects we investigated whether the use of autologous derived platelet gel and fibrin sealant would reduce postoperative blood loss, decrease the impaired range of motion and the incidence of arthrofibrosis. All patients were consecutively operated and assigned to the study or control groups. Study group patients (n = 85) were treated with the application of autologous platelet gel and fibrin sealant at the end of surgery. Eighty patients were operated without the use of platelet gel and fibrin sealant, and served as the control group. The postoperative hemoglobin decrease, range of motion and length of hospitalization were recorded. During a 5-month postoperative period patients were followed to observe the incidence of arthrofibrosis. In patients in the treatment group the hemoglobin concentration in blood decreased significantly less when compared to the control group. They also showed a superior postoperative range of motion when compared to those of the control group (P < 0.001). The incidence of arthrofibrosis and subsequent forced manipulation was significantly less (P < 0.001) in patients managed with platelet gel and fibrin sealant. We conclude that peri-operatively applied platelet gel and fibrin sealant may improve the range of motion after total knee arthroplasty, decreases the length of stay and may reduce the incidence of arthrofibrosis.
Everts
Peter A M
PA
Department of Peri-Operative Blood Management, Catharina Hospital, Eindhoven, The Netherlands. everts@elive.nl
Devilee
Roger J J
RJ
Oosterbos
Cornelis J M
CJ
Mahoney
Christine Brown
CB
Schattenkerk
Maarten Eeftinck
ME
Knape
Johannes T A
JT
van Zundert
André
A
D000368:Aged; D019645:Arthroplasty, Replacement, Knee / Q000379:methods*; D001804:Blood Transfusion, Autologous; D005260:Female; D015718:Fibrin Tissue Adhesive / Q000627:therapeutic use*; D005355:Fibrosis / Q000517:prevention & control; D005500:Follow-Up Studies; D005782:Gels; D006454:Hemoglobins / Q000032:analysis; D006490:Hemostatics / Q000627:therapeutic use*; D006801:Humans; D007719:Knee Joint / Q000473:pathology / Q000502:physiology / Q000601:surgery; D007902:Length of Stay / Q000706:statistics & numerical data; D008297:Male; D020370:Osteoarthritis, Knee / Q000601:surgery; D017713:Platelet Transfusion / Q000379:methods*; D016059:Range of Motion, Articular / Q000502:physiology; D020127:Recovery of Function / Q000502:physiology
D015718:Fibrin Tissue Adhesive; D005782:Gels; D006454:Hemoglobins; D006490:Hemostatics